Clinical Pharmacy cardiovascular system

myocardial infarction

Topic overview

Start with the big picture

The lesson organizes acute MI care from immediate management through reperfusion, antithrombotic therapy, adjunctive pharmacotherapy, and follow-up. It describes symptom-relief measures, the preference for primary PCI when timely, and fibrinolytic therapy when PCI is unavailable within the stated window. It also surveys dual antiplatelet therapy and anticoagulation, followed by therapies such as beta-blockers, ACE inhibitors or ARBs, statins, and selected aldosterone antagonists. Treatment choices depend on clinical features and contraindications—for example, ventricular function, heart failure, blood pressure, and bleeding risk. Monitoring, patient education, adherence, and interaction awareness are also part of the broader care pathway.

Learning objectives

What you'll learn

  • Outline the immediate management measures described for acute myocardial infarction.
  • Compare the lesson’s primary PCI and fibrinolysis pathways.
  • Describe the roles of antiplatelet and anticoagulant therapy during MI care.
  • Identify clinical factors that influence adjunctive and secondary-prevention medication choices.
  • Recognize monitoring, adherence, and patient-education themes in follow-up care.
Ready for the complete lesson?

Continue your study

Work through the complete notes and reinforce the topic with the study tools available in the full lesson.

PharmaProLearn

Excel Beyond Limits